Document is current
Any future updates will be listed below
-
Authors
Lindholm, Agnes
Abrahamsen, Marie-Louise
Buch-Larsen, Kristian
Marina, Djordje
Andersson, Michael
Helge, Jørn Wulff
Schwarz, Peter
Dela, Flemming
Gillberg, Linn
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03784651 at ClinicalTrials.govDocuments that mention this clinical trial
Pro-inflammatory cytokines increase temporarily after adjuvant treatment for breast cancer in postmenopausal women: a longitudinal study
https://doi.org/10.1186/s13058-024-01898-3
-
Funding
Funding for this research was provided by:
Svend Andersen Fonden
Aase og Ejnar Danielsens Fond
Danish Diabetes and Endocrine Academy (NNF17SA0031406)
Dagmar Marshalls Fond
Copenhagen University
- License Information
-
More Information
Article History
Received: 5 March 2024
Accepted: 1 October 2024
First Online: 16 October 2024
Declarations
:
: The study “Healthy living after breast cancer” was performed in accordance with the ethical principles of the Declaration of Helsinki (Estd. 1964) and approved by the Ethics Committee of The Capital Region of Denmark (Project number H-18016600 approved on the 21st of June 2018 and amendment 67762). Similarly, the study involving 36 of the control participants was approved by the by the Ethics Committee of The Capital Region of Denmark (H-19034328) and adhered to the principles of the Declaration of Helsinki. All patients and controls included signed a written informed consent before enrolment to the studies. Patients could withdraw their consent and choose to be excluded from the studies at any given time.
: Not applicable.
: The authors declare no competing interests.
